Ivermectin gets green light after lobby, but experts await better data sets

Pundits are divided, but the regulatory authority has, with caution, introduced a ‘controlled-access programme’

27 January 2021 - 19:41 By tanya farber

It’s the drug everyone’s talking about and ivermectin will now make its way, legitimately, into the hands of doctors countrywide as they try to save patients from a Covid-19 death...

This article is free to read if you sign up or sign in.

If you have already registered or subscribed, please sign in to continue.



Questions or problems? Email helpdesk@timeslive.co.za or call 0860 52 52 00.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.